MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ANVS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Annovis Bio (ANVS) Ownership - Who owns Annovis Bio?

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
77.43M
P/E Ratio
N/A
Total Cash
15.29M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
3.22
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ANVS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ANVS
A.I. Advisor
published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com